This report presents a detailed, data-driven analysis of the global Blood Glucose Monitoring Devices Market size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic intelligence.
I recently came across a report by Roots Analysis that really put things into perspective. According to them, The blood glucose monitoring devices market size, valued at USD 24.2 billion in 2025, is projected to reach USD 26.5 billion in 2026 and USD 34 billion by 2030, with a CAGR of 6.3% during the forecast period 2026 to 2030.
Read More: https://www.rootsanalysis.com/reports/diabetes-monitoring-devices-market.html
Market Segmentation
Type of Device:-self-monitoring blood glucose device and continuous blood glucose monitoring device.
Diabetes Type:- Type 1 diabetes and Type 2 diabetes.
Device Component:-
self-monitoring blood glucose devices: lancing device, blood glucose meter and testing strips;
continuous glucose monitoring devices: sensors, transmitter and receiver.
Key Geographies
North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
Each segment is analyzed by volume, value, and growth patterns, offering a comparative understanding of usage trends and market opportunities.
Key Players Include:
Andermatt
Bayer
BioSafe Systems
Certis Biologicals
Corteva Agriscience
Novozymes
Nutri-Tech Solutions
ProFarm
Syngenta
Valent Biosciences
These companies are assessed based on their contributions to market share, innovation, and responsiveness to global and regional demand shifts.
Regional Insights
Each region is evaluated based on:
Historical market trends and sales data
Regulatory frameworks
Product availability and distribution strength
Emerging opportunities and constraints
Comparative regional analysis enables better targeting of expansion strategies and investment planning.
Supply Chain & Operational Overview
This section covers:
Pricing structures
Distribution channels
Manufacturing capabilities
Cost breakdowns and logistics trends
Understanding operational flows adds value to strategic sourcing and capacity expansion discussions.
Research Methodology
This report is developed using a combination of:
Primary research: Expert interviews, corporate disclosures
Secondary research: Company websites, public filings, databases, and published literature
All data points were reviewed for consistency, ensuring neutrality, reliability, and practical relevance for stakeholders and strategic planners.
Conclusion and Customization
This Blood Glucose Monitoring Devices Market report serves as a foundational reference for:
Market entry and expansion strategies
Product development roadmaps
Investment decision-making
For custom data slices or tailored analysis by geography, product, or competitor, please contact sales@rootsanalysis.com.
This report presents a detailed, data-driven analysis of the global Blood Glucose Monitoring Devices Market size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic intelligence.
I recently came across a report by Roots Analysis that really put things into perspective. According to them, The blood glucose monitoring devices market size, valued at USD 24.2 billion in 2025, is projected to reach USD 26.5 billion in 2026 and USD 34 billion by 2030, with a CAGR of 6.3% during the forecast period 2026 to 2030.
Read More: https://www.rootsanalysis.com/reports/diabetes-monitoring-devices-market.html
Market Segmentation
Type of Device:-self-monitoring blood glucose device and continuous blood glucose monitoring device.
Diabetes Type:- Type 1 diabetes and Type 2 diabetes.
Device Component:-
self-monitoring blood glucose devices: lancing device, blood glucose meter and testing strips;
continuous glucose monitoring devices: sensors, transmitter and receiver.
Key Geographies
North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
Each segment is analyzed by volume, value, and growth patterns, offering a comparative understanding of usage trends and market opportunities.
Key Players Include:
Andermatt
Bayer
BioSafe Systems
Certis Biologicals
Corteva Agriscience
Novozymes
Nutri-Tech Solutions
ProFarm
Syngenta
Valent Biosciences
These companies are assessed based on their contributions to market share, innovation, and responsiveness to global and regional demand shifts.
Regional Insights
Each region is evaluated based on:
Historical market trends and sales data
Regulatory frameworks
Product availability and distribution strength
Emerging opportunities and constraints
Comparative regional analysis enables better targeting of expansion strategies and investment planning.
Supply Chain & Operational Overview
This section covers:
Pricing structures
Distribution channels
Manufacturing capabilities
Cost breakdowns and logistics trends
Understanding operational flows adds value to strategic sourcing and capacity expansion discussions.
Research Methodology
This report is developed using a combination of:
Primary research: Expert interviews, corporate disclosures
Secondary research: Company websites, public filings, databases, and published literature
All data points were reviewed for consistency, ensuring neutrality, reliability, and practical relevance for stakeholders and strategic planners.
Conclusion and Customization
This Blood Glucose Monitoring Devices Market report serves as a foundational reference for:
Market entry and expansion strategies
Product development roadmaps
Investment decision-making
For custom data slices or tailored analysis by geography, product, or competitor, please contact sales@rootsanalysis.com.